Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT04723095
Status
Recruiting
Apply to this trial

Conditions

  • Cervical Large Cell Neuroendocrine Carcinoma
  • Cervical Neuroendocrine Carcinoma
  • Cervical Small Cell Carcinoma
  • Cervical Undifferentiated Carcinoma
  • Stage I Cervical Cancer AJCC v8
  • Stage IA Cervical Cancer AJCC v8
  • Stage IA1 Cervical Cancer AJCC v8
  • Stage IA2 Cervical Cancer AJCC v8
  • Stage IB Cervical Cancer AJCC v8
  • Stage IB1 Cervical Cancer AJCC v8
  • Stage IB2 Cervical Cancer AJCC v8
  • Stage II Cervical Cancer AJCC v8
  • Stage IIA Cervical Cancer AJCC v8
  • Stage IIA1 Cervical Cancer AJCC v8
  • Stage IIA2 Cervical Cancer AJCC v8
  • Stage IIB Cervical Cancer AJCC v8
  • Stage III Cervical Cancer AJCC v8
  • Stage IIIA Cervical Cancer AJCC v8
  • Stage IIIB Cervical Cancer AJCC v8
  • Stage IV Cervical Cancer AJCC v8
  • Stage IVA Cervical Cancer AJCC v8
  • Stage IVB Cervical Cancer AJCC v8

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Follow-Up — OTHER
    Receive follow up
  • Medical Chart Review — OTHER
    Review of medical records

Study Details

This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.

Key Dates

Start date
May 16, 2013
Status verified
Mar 2026
Primary completion
Jan 1, 2044
Completion
Jan 1, 2044

Study Design

Enrollment
750 participants (estimated)

Arms

  • Arm: Observational (medical chart review)
    Patients' medical records are reviewed retrospectively and prospectively. All prospective patients will be contacted via email, telephone, or U.S. Mail on case by case basis for up to 10 years to check status of disease and any further treatment received. Project staff can also access the patient's M. D. Anderson Epic medical record for updates. Request for additional clinic and treatment notes will be submitted to external medical institutions listed in the physician information form in order to access updated notes for non- M. D. Anderson patients.

Primary Outcome Measure

Disease characterization data [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Larissa A. Meyer, MD
[email protected]
713-745-0973
Larissa A. Meyer, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies